Antony Riley - Chief Financial Officer, Forte Biosciences, Inc

As of January 18, 2022


Antony Riley Net Worth

  • Net worth is estimated to be at least $748.92K
  • Owns at least 11,065 units of Forte Biosciences, Inc stock
  • Sold an estimated value of $106.11K in the last 2 years at Forte Biosciences, Inc

Antony Riley Compensation at Forte Biosciences, Inc in 2020

  • Earned a $264,075 salary and a $110 bonus
  • Received a total compensation of $1,056,250

Antony Riley Trading

  • Largest purchase of shares was 6,700 units , worth over $96.45K on June 30, 2020
  • Largest sale of shares was 25,000 units , worth over $106.11K on September 7, 2021
  • In total has made about 4 transactions over 2 years
  • Usually trades in January, September, April and June, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Antony Riley Mailing Address

  • Mailing address is C/o Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 94538 PA

Forte Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Paul A. Wagner, Ph.D. 2020 $452,917 $324,000 - - - $776,917
Paul A. Wagner, Ph.D. 2019 $350,000 $175,000 - - - $525,000
Marty J. Duvall 2020 $233,731 - $76,920 - $862,899 $1,173,550
Marty J. Duvall 2019 $515,000 - - $1,257,437 $474 $1,772,911
Antony Riley 2020 $264,075 $110,000 - $682,175 - $1,056,250
Antony Riley 2019 - - - - - -
Mark Foletta 2020 $180,000 - $51,275 - $458,686 $689,961
Mark Foletta 2019 $388,308 - - $592,443 $360 $981,111
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1419041/000119312521144995/d341393ddef14a.htm

Forte Biosciences, Inc Insider Trading

  • The most recent transaction was 1,000,000 units sold on September 8, 2021 by Paul Wagner worth over $4.35M
  • In the last year, insiders at Forte Biosciences, Inc sold an estimated value of $4.45M and bought an estimated value of $202.59K
  • The most active traders are Paul A Wagner, See Remarks,  Antony Riley, Chief Financial Officer,  and Allen Donald Williams, Director
  • Insider trading is most common in June, with the busiest year in 2021 and 2022

Forte Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1